Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CureVac (CVAC) Goodwill & Intangibles (2019 - 2025)

Historic Goodwill & Intangibles for CureVac (CVAC) over the last 7 years, with Q3 2025 value amounting to $28.9 million.

  • CureVac's Goodwill & Intangibles rose 12.53% to $28.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.9 million, marking a year-over-year increase of 12.53%. This contributed to the annual value of $26.9 million for FY2024, which is 1186.62% down from last year.
  • CureVac's Goodwill & Intangibles amounted to $28.9 million in Q3 2025, which was up 12.53% from $28.4 million recorded in Q2 2025.
  • CureVac's Goodwill & Intangibles' 5-year high stood at $34.5 million during Q2 2023, with a 5-year trough of $13.1 million in Q2 2022.
  • For the 5-year period, CureVac's Goodwill & Intangibles averaged around $26.5 million, with its median value being $28.8 million (2024).
  • Its Goodwill & Intangibles has fluctuated over the past 5 years, first skyrocketed by 13505733.23% in 2021, then tumbled by 3281.24% in 2022.
  • Quarter analysis of 5 years shows CureVac's Goodwill & Intangibles stood at $15.1 million in 2021, then skyrocketed by 114.09% to $32.4 million in 2022, then dropped by 5.93% to $30.5 million in 2023, then dropped by 11.87% to $26.9 million in 2024, then grew by 7.34% to $28.9 million in 2025.
  • Its Goodwill & Intangibles stands at $28.9 million for Q3 2025, versus $28.4 million for Q2 2025 and $26.0 million for Q1 2025.